loading

Vtv Therapeutics Inc Stock (VTVT) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
1.00
- - - -
Operating Expenses
40.79%
6.627
4.707 5.368 8.00 7.427
Benefits Costs and Expenses
6.919
- - - -
Costs And Expenses
6.919
- - - -
Operating Income/Loss
19.55%
-5.627
-4.707 -5.368 -8.00 -7.427
Income/Loss From Continuing Operations Before Tax
33.28%
-5.919
-4.441 -8.54 -7.211 -5.774
Income Tax Expense/Benefit
0.10
- - - -
Income/Loss From Continuing Operations After Tax
35.53%
-6.019
-4.441 -8.54 -7.211 -5.774
Net Income/Loss
35.53%
-6.019
-4.441 -8.54 -7.211 -5.774
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
19.83%
-1.154
-0.963 -1.886 -1.592 -1.275
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):